Issues in Clinical Trial Design in Stem Cell Trials After Stroke




10.

Watanabe K, Bois FY, Zeise L. Interspecies extrapolation: a reexamination of acute toxicity data. Risk Anal. 1992;12:301–10.PubMed


11.

Davidson IW, Parker JC, Beliles RP. Biological basis for extrapolation across mammalian species. Regul Toxicol Pharmacol. 1986;6:211–37.PubMed


12.

Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers USDoHaHSFaDA. 2005.


13.

Li S, Carmichael ST. Growth-associated gene and protein expression in the region of axonal sprouting in the aged brain after stroke. Neurobiol Dis. 2006;23:362–73.PubMed


14.

Stroemer R, Kent T, Hulsebosch C. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with d-amphetamine therapy after neocortical infarction in rats. Stroke. 1998;29:2381–95.PubMed


15.

Jones T, Schallert T. Overgrowth and pruning of dendrites in adult rats recovering from neocortical damage. Brain Res. 1992;581:156–60.PubMed


16.

Ren J, Kaplan P, Charette M, Speller H, Finklestein S. Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke. Neuropharmacology. 2000;39:860–5.PubMed


17.

Biernaskie J, Chernenko G, Corbett D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci. 2004;24:1245–54.PubMed


18.

Winstein CJ, Wolf SL, Dromerick AW, Lane CJ, Nelsen MA, Lewthwaite R, et al. Interdisciplinary comprehensive arm rehabilitation evaluation (icare): a randomized controlled trial protocol. BMC Neurol. 2013;13:5.PubMedCentralPubMed


19.

Yozbatiran N, Der-Yeghiaian L, Cramer SC. A standardized approach to performing the action research arm test. Neurorehabil Neural Repair. 2008;22:78–90.PubMed


20.

See J, Dodakian L, Chou C, Chan V, McKenzie A, Reinkensmeyer DJ, et al. A standardized approach to the fugl-meyer assessment and its implications for clinical trials. Neurorehabil Neural Repair. 2013;27:732–41.PubMed


21.

Adkins-Muir D, Jones T. Cortical electrical stimulation combined with rehabilitative training: enhanced functional recovery and dendritic plasticity following focal cortical ischemia in rats. Neurol Res. 2003;25:780–8.PubMed


22.

Kleim J, Bruneau R, VandenBerg P, MacDonald E, Mulrooney R, Pocock D. Motor cortex stimulation enhances motor recovery and reduces peri-infarct dysfunction following ischemic insult. Neurol Res. 2003;25:789–93.PubMed


23.

Plautz E, Barbay S, Frost S, Friel K, Dancause N, Zoubina E, et al. Post-infarct cortical plasticity and behavioral recovery using concurrent cortical stimulation and rehabilitative training: a feasibility study in primates. Neurol Res. 2003;25:801–10.PubMed


24.

Teskey G, Flynn C, Goertzen C, Monfils M, Young N. Cortical stimulation improves skilled forelimb use following a focal ischemic infarct in the rat. Neurol Res. 2003;25:794–800.PubMed


25.

Levy R, Benson R, Winstein C, for the Everest Study Investigators. Cortical stimulation for upper-extremity hemiparesis from ischemic stroke: Everest study primary endpoint results. International Stroke Conference. 2008.


26.

Nouri S, Cramer SC. Anatomy and physiology predict response to motor cortex stimulation after stroke. Neurology. 2011 Sep 13;77(11):1076–83.PubMedCentralPubMed


27.

Calautti C, Baron J. Functional neuroimaging studies of motor recovery after stroke in adults: a review. Stroke. 2003;34:1553–66.PubMed


28.

Cramer SC. Repairing the human brain after stroke. Ii. Restorative therapies. Ann Neurol. 2008;63:549–60.PubMed


29.

Lyden P, Lau G. A critical appraisal of stroke evaluation and rating scales. Stroke. 1991;22:1345–52.PubMed


30.

Gresham G, Duncan P, Stason W, Adams H, Adelman A, Alexander D, et al. Post-stroke rehabilitation. Rockville: U.S. Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research; 1995.


31.

Barak S, Duncan PW. Issues in selecting outcome measures to assess functional recovery after stroke. Neuro Rx. 2006;3:505–24.


32.

Baker K, Cano SJ, Playford ED. Outcome measurement in stroke: a scale selection strategy. Stroke. 2011;42:1787–94.PubMed


33.

Lees KR, Bath PM, Schellinger PD, Kerr DM, Fulton R, Hacke W, et al. Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke. 2012;43:1163–70.PubMed


34.

World Health Organization. International classification of functioning, disability and health (icf). Geneva: World Health Organization; 2008.


35.

Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, et al. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American heart association. Stroke. 2010;41:2402–48.PubMed


36.

Wood-Dauphinee S, Williams J, Shapiro S. Examing outcome measures in a clinical study of stroke. Stroke. 1990;21:731–9.PubMed


37.

Dobkin B. The clinical science of neurologic rehabilitation. New York: Oxford University Press; 2003.


38.

Cramer S, Nelles G, Schaechter J, Kaplan J, Finklestein S. Computerized measurement of motor performance after stroke. Stroke. 1997;28:2162–8.PubMed


39.

Stewart JC, Cramer SC. Patient-reported measures provide unique insights into motor function after stroke. Stroke. 2013;44:1111–6.PubMedCentralPubMed


40.

Duncan PW, Samsa GP, Weinberger M, Goldstein LB, Bonito A, Witter DM, et al. Health status of individuals with mild stroke. Stroke. 1997;28:740–5.PubMed


41.

Edwards DF, Hahn M, Baum C, Dromerick AW. The impact of mild stroke on meaningful activity and life satisfaction. J Stroke Cerebrovasc Dis. 2006;15:151–7.PubMed


42.

Carlsson GE, Moller A, Blomstrand C. Consequences of mild stroke in persons < 75 years–a 1-year follow-up. Cerebrovas Dis. (Basel, Switzerland). 2003;16:383–8.


43.

Barrett AM. Rose-colored answers: neuropsychological deficits and patient-reported outcomes after stroke. Behav Neurol. 2010;22:17–23.PubMed


44.

Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012 Oct;21(8):1305–14.


45.

Department of Health. Equity and excellence: liberating the NHS. London: Department of Health; 2010.


46.

Promis. Dynamic tools to measure health outcomes from the patient perspective. http://​nihpromis.​Org/​. Zugegriffen: 01. Oct. 2014.


47.

Luce R, Narens L. Measurement scales on the continuum. Science. 1987;236:1527–32.PubMed


48.

Cramer SC, Koroshetz WJ, Finklestein SP. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke. 2007;38:1393–5.PubMed


49.

Cramer SC, Fitzpatrick C, Warren M, Hill MD, Brown D, Whitaker L, et al. The beta-hcg+erythropoietin in acute stroke (betas) study: a 3-center, single-dose, open-label, noncontrolled, phase iia safety trial. Stroke. 2010;41:927–31.PubMedCentralPubMed


50.

Roth EJ, Heinemann AW, Lovell LL, Harvey RL, McGuire JR, Diaz S. Impairment and disability: their relation during stroke rehabilitation. Arch Phys Med Rehabil. 1998;79:329–35.PubMed


51.

Bath PM, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, et al. Statistical analysis of the primary outcome in acute stroke trials. Stroke. 2012;43:1171–8.PubMed

Oct 22, 2016 | Posted by in NEUROSURGERY | Comments Off on Issues in Clinical Trial Design in Stem Cell Trials After Stroke

Full access? Get Clinical Tree

Get Clinical Tree app for offline access